Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 784

Related Citations for PubMed (Select 16426083)

1.

High-dose sertraline strategy for nonresponders to acute treatment for obsessive-compulsive disorder: a multicenter double-blind trial.

Ninan PT, Koran LM, Kiev A, Davidson JR, Rasmussen SA, Zajecka JM, Robinson DG, Crits-Christoph P, Mandel FS, Austin C.

J Clin Psychiatry. 2006 Jan;67(1):15-22.

PMID:
16426083
2.

Sertraline and fluoxetine treatment of obsessive-compulsive disorder: results of a double-blind, 6-month treatment study.

Bergeron R, Ravindran AV, Chaput Y, Goldner E, Swinson R, van Ameringen MA, Austin C, Hadrava V.

J Clin Psychopharmacol. 2002 Apr;22(2):148-54.

PMID:
11910259
3.

A 1 year double-blind placebo-controlled fixed dose study of sertraline in the treatment of obsessive-compulsive disorder.

Greist JH, Jefferson JW, Kobak KA, Chouinard G, DuBoff E, Halaris A, Kim SW, Koran L, Liebowtiz MR, Lydiard B, et al.

Int Clin Psychopharmacol. 1995 Jun;10(2):57-65.

PMID:
7673657
4.

Placebo-controlled, multicenter study of sertraline treatment for obsessive-compulsive disorder.

Kronig MH, Apter J, Asnis G, Bystritsky A, Curtis G, Ferguson J, Landbloom R, Munjack D, Riesenberg R, Robinson D, Roy-Byrne P, Phillips K, Du Pont IJ.

J Clin Psychopharmacol. 1999 Apr;19(2):172-6.

PMID:
10211919
5.

A double-blind, placebo-controlled study of the efficacy and safety of controlled-release fluvoxamine in patients with obsessive-compulsive disorder.

Hollander E, Koran LM, Goodman WK, Greist JH, Ninan PT, Yang H, Li D, Barbato LM.

J Clin Psychiatry. 2003 Jun;64(6):640-7.

PMID:
12823077
6.

A randomized clinical trial of cognitive-behavioral group therapy and sertraline in the treatment of obsessive-compulsive disorder.

Sousa MB, Isolan LR, Oliveira RR, Manfro GG, Cordioli AV.

J Clin Psychiatry. 2006 Jul;67(7):1133-9.

PMID:
16889458
7.
8.

Augmentation of serotonin reuptake inhibitors in refractory obsessive-compulsive disorder using adjunctive olanzapine: a placebo-controlled trial.

Bystritsky A, Ackerman DL, Rosen RM, Vapnik T, Gorbis E, Maidment KM, Saxena S.

J Clin Psychiatry. 2004 Apr;65(4):565-8.

PMID:
15119922
9.

Long-term sertraline treatment of children and adolescents with obsessive-compulsive disorder.

Cook EH, Wagner KD, March JS, Biederman J, Landau P, Wolkow R, Messig M.

J Am Acad Child Adolesc Psychiatry. 2001 Oct;40(10):1175-81.

PMID:
11589530
10.
11.

Sertraline treatment of panic disorder: response in patients at risk for poor outcome.

Pollack MH, Rapaport MH, Clary CM, Mardekian J, Wolkow R.

J Clin Psychiatry. 2000 Dec;61(12):922-7.

PMID:
11206597
12.

Results of a double-blind placebo controlled trial of a new serotonin uptake inhibitor, sertraline, in the treatment of obsessive-compulsive disorder.

Chouinard G, Goodman W, Greist J, Jenike M, Rasmussen S, White K, Hackett E, Gaffney M, Bick PA.

Psychopharmacol Bull. 1990;26(3):279-84.

PMID:
2274626
13.

Multicenter double-blind comparison of sertraline and desipramine for concurrent obsessive-compulsive and major depressive disorders.

Hoehn-Saric R, Ninan P, Black DW, Stahl S, Greist JH, Lydiard B, McElroy S, Zajecka J, Chapman D, Clary C, Harrison W.

Arch Gen Psychiatry. 2000 Jan;57(1):76-82.

PMID:
10632236
14.

Quetiapine addition to serotonin reuptake inhibitors in patients with severe obsessive-compulsive disorder: a double-blind, randomized, placebo-controlled study.

Kordon A, Wahl K, Koch N, Zurowski B, Anlauf M, Vielhaber K, Kahl KG, Broocks A, Voderholzer U, Hohagen F.

J Clin Psychopharmacol. 2008 Oct;28(5):550-4. doi: 10.1097/JCP.0b013e318185e735.

PMID:
18794652
15.

Citalopram intravenous infusion in resistant obsessive-compulsive disorder: an open trial.

Pallanti S, Quercioli L, Koran LM.

J Clin Psychiatry. 2002 Sep;63(9):796-801.

PMID:
12363120
16.

A 2-year study of sertraline in the treatment of obsessive-compulsive disorder.

Rasmussen S, Hackett E, DuBoff E, Greist J, Halaris A, Koran LM, Liebowitz M, Lydiard RB, McElroy S, Mendels J, O'Connor K.

Int Clin Psychopharmacol. 1997 Nov;12(6):309-16.

PMID:
9547132
17.

Sertraline treatment of posttraumatic stress disorder: results of 24 weeks of open-label continuation treatment.

Londborg PD, Hegel MT, Goldstein S, Goldstein D, Himmelhoch JM, Maddock R, Patterson WM, Rausch J, Farfel GM.

J Clin Psychiatry. 2001 May;62(5):325-31.

PMID:
11411812
18.

Double-blind parallel comparison of three dosages of sertraline and placebo in outpatients with obsessive-compulsive disorder.

Greist J, Chouinard G, DuBoff E, Halaris A, Kim SW, Koran L, Liebowitz M, Lydiard RB, Rasmussen S, White K, et al.

Arch Gen Psychiatry. 1995 Apr;52(4):289-95.

PMID:
7702445
19.

Treatment of dysthymia with sertraline: a double-blind, placebo-controlled trial in dysthymic patients without major depression.

Ravindran AV, Guelfi JD, Lane RM, Cassano GB.

J Clin Psychiatry. 2000 Nov;61(11):821-7.

PMID:
11105734
20.

Venlafaxine extended release versus citalopram in patients with depression unresponsive to a selective serotonin reuptake inhibitor.

Lenox-Smith AJ, Jiang Q.

Int Clin Psychopharmacol. 2008 May;23(3):113-9. doi: 10.1097/YIC.0b013e3282f424c2.

PMID:
18408525
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk